Serum amyloid A (SAA) is a major acute-phase protein that increases rapidly in response to inflammatory stimuli such as bacterial or viral infections, trauma, surgery, and autoimmune disorders. The Biotime SAA Rapid Quantitative Test provides fast and reliable detection of SAA levels in whole blood, plasma, or serum samples, enabling early clinical intervention.

SAA serves as a non-invasive biomarker for monitoring disease progression and therapeutic response, including in organ transplantation, acute myocardial infarction, and autoimmune diseases. The test is highly sensitive, requiring only a small sample volume, and delivers accurate results in just three minutes, making it ideal for ICU, emergency, and laboratory applications.